Company news

Laboratorios Farmaceuticos Rovi, S.A. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

First half 2026 results press release

July 23, 2026

ROVI and the Regional Government of Castilla-La Mancha promote a framework of collaboration to modernise healthcare services through technological innovation

July 8, 2026

First three months of 2026 results press release

May 6, 2026

Laboratorios Farmaceuticos Rovi: 2025 results press release

February 25, 2026

Laboratorios Farmaceuticos Rovi: ROVI releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development

November 18, 2025

First nine months of 2025 results press release

November 6, 2025

Laboratorios Farmaceuticos Rovi: ROVI announces a collaboration with Roche for the manufacture of a new medicine in development

October 21, 2025

Laboratorios Farmaceuticos Rovi: ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)

September 29, 2025

First half 2025 results press release

July 24, 2025

ROVI held its 2025 General Shareholders’ Meeting

June 18, 2025

First three months 2025 results press release

May 8, 2025

2025 Capital Markets Day presentation

March 25, 2025

Laboratorios Farmaceuticos Rovi: 2024 results press release

February 25, 2025

First nine months 2024 results press release

November 7, 2024

Laboratorios Farmaceuticos Rovi: ROVI completes the strategic review of its CDMO business

October 24, 2024

First half 2024 results press release

July 31, 2024

Laboratorios Farmaceuticos Rovi: ROVI invests 60 million euros to expand the production capacity of its San Sebastián de los Reyes plant by 31.5%

July 11, 2024

Laboratorios Farmaceuticos Rovi: ROVI forecasts potential Risperidone ISM® sales of between 200 and 300 million euros globally in upcoming years

June 24, 2024

Laboratorios Farmaceuticos Rovi: ROVI completes its new Escúzar plant by including a sodium heparin production facility

June 20, 2024

First three months 2024 results press release

May 8, 2024

Laboratorios Farmaceuticos Rovi: ROVI announces agreement to manufacture pre-filled syringes

April 25, 2024

ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies

March 12, 2024

First nine months 2023 results press release

November 10, 2023

Laboratorios Farmaceuticos Rovi: ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®

July 28, 2023

First half 2023 results press release

July 26, 2023

First quarter 2023 results press release

May 10, 2023

Calls

Decks

The 5 newest of 37 decks. Every deck is listed under its year.